Tais de Cassia Ribeiro

Mrs. Tais de Cassia Ribeiro


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RSRafael Miguel Sábio
Rafael Miguel Sábio
AMAndréia B. Meneguin
Andréia B. Meneguin
TRTais de Cassia Ribeiro
Tais de Cassia Ribeiro
RSRobson Silva
Robson Silva
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

19 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TRTais de Cassia Ribeiro
Tais de Cassia Ribeiro
RSRafael Miguel Sábio
Rafael Miguel Sábio
MLMarcela Tavares Luiz
Marcela Tavares Luiz
Lucas Canto-de-SouzaLucas Canto-de-Souza
Lucas Canto-de-Souza
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive and behavioral impairment. Curcumin-loaded mesoporous silica nanoparticles (MSN-CCM) can overcome the drawbacks related to the free curcumin (CCM) clinical application, such as water insolubility and low bioavailability, besides acting over the main causes associated to AD. A thermo-responsive hydrogel is an interesting approach for facilitating the administration of the nanosystem via a nasal route, as well as for overcoming mucociliary clearance mechanisms. In light of this, MSN-CCM were dispersed in the hydrogel and evaluated through in vitro and in vivo assays. The MSNs and MSN-CCM were successfully characterized by physicochemical analysis and a high value of the CCM encapsulation efficiency (EE%, 87.70 ± 0.05) was achieved. The designed thermo-responsive hydrogel (HG) was characterized by rheology, texture profile analysis, and ex vivo mucoadhesion, showing excellent mechanical and mucoadhesive properties. Ex vivo permeation studies of MSN-CCM and HG@MSN-CCM showed high permeation values (12.46 ± 1.08 and 28.40 ± 1.88 μg cm−2 of CCM, respectively) in porcine nasal mucosa. In vivo studies performed in a streptozotocin-induced AD model confirmed that HG@MSN-CCM reverted the cognitive deficit in mice, acting as a potential formulation in the treatment of AD.

21 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Jonatas DuarteJonatas Duarte
Jonatas Duarte
LFLeonardo Delello Di Filippo
Leonardo Delello Di Filippo
TRTais de Cassia Ribeiro
Tais de Cassia Ribeiro
ASAna Carolina de Jesus Silva
Ana Carolina de Jesus Silva
Lorane Hage-MelimLorane Hage-Melim
Lorane Hage-Melim
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Aedes mosquito-borne diseases remain a significant global health threat, necessitating effective control strategies. This study introduces monoterpenes-based nanohydrogels for potential use as repellents against Aedes aegypti, the primary dengue vector worldwide. We formulated hydrogels using cymene- and myrcene-based nanoemulsions with different polymers: chitosan, carboxymethylcellulose (CMC), and carbopol®. Our evaluations of rheological, texture, and bioadhesive properties identified CMC hydrogel as the most promising gelling agent for topical application, exhibiting sustained monoterpene release over 12 h with low skin permeation and high retention in the stratum corneum. Myrcene-loaded CMC hydrogel achieved a 57% feeding deterrence compared to 47% with cymene hydrogel in the mosquito membrane-feeding model. Molecular docking studies revealed interactions between myrcene and an essential amino acid (Ile116) in the Ae. aegypti odorant-binding protein 22 (AeOBP22), corroborating its higher repellent efficacy. These findings suggest that myrcene-loaded CMC hydrogels offer a promising, minimally invasive strategy for personal protection against Ae. aegypti and warrant further investigation to optimize monoterpene concentrations for vector control.
1